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Background: Single-limb knee extension exercises have been found to be effective at improving lower extremity
exercise capacity in patients with chronic obstructive pulmonary disease (COPD). Since the positive local
physiological effects of exercise training only occur in the engaged muscle(s), should upper extremity muscles also
be included to determine the effect of single limb exercises in COPD patients.
Methods/design: Trial design: a prospective, assessor-blind, block randomized controlled, parallel-group
multicenter trial. Participants: stage II-IV COPD patients, > 40 years of age, ex-smokers, with stable medical
treatment will be included starting May 2011. Recruitment at three locations in Sweden. Interventions: 1)
high-repetitive single limb exercise (HRSLE) training with elastic bands, 60 minutes, three times/week for 8 weeks
combined with four sessions of 60 minutes patient education, or 2) the same patient education alone. Outcomes:
Primary: determine the effects of HRSLE on local muscle endurance capacity (measured as meters walked during
6-minute walk test and rings moved on 6-minute ring and pegboard test) and quality of life (measured as change
on the Swedish version of the Chronic Respiratory Disease Questionnaire). Secondary: effects on maximal strength,
muscular endurance, dyspnea, self-efficacy, anxiety and depression. The relationship between changes in
health-related variables and changes in exercise capacity, sex-related differences in training effects, feasibility of
the program, strategies to determine adequate starting resistance and provide accurate resistance for each involved
movement and the relationship between muscle fatigue and dyspnea in the different exercise tests will also be
analyzed. Randomization: performed by a person independent of the recruitment process and using a computer
random number generator. Stratification by center and gender with a 1:1 allocation to the intervention or control
using random block sizes. Blinding: all outcome assessors will be blinded to group assignment.
Discussion: The results of this project will contribute to increase the body of knowledge regarding COPD
and HRSLE.
Trial registration: ClinicalTrials.gov Identifier: NCT01354067. Registration date: 2011-05-11. First participant
randomized: 2011-09-02
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Chronic obstructive pulmonary disease (COPD) is a
major cause of chronic morbidity and mortality in the
world [1]. COPD was originally a disease more com-
monly seen in men, but now the disease affects men and
women almost equally, as observed in international data
[2]. Furthermore, women seem to be more sensitive to
the negative effects of tobacco smoke, and develop very
severe COPD to a larger extent compared to men [3].
Female COPD patients also demonstrate lower quality of
life (QoL), more severe dyspnea and more sensitive air-
ways than men with the same degree of airway obstruc-
tion [4]. Exercise intolerance is the key disabling factor
in COPD, with decreased exercise capacity, increased leg
fatigue and dyspnea among the most frequently reported
symptoms [5]. Peripheral muscle weakness has been
shown to contribute to exercise intolerance in COPD
patients [6]. Nevertheless, Serres and colleagues [7]
argued that muscle weakness alone does not explain the
decreased peripheral muscle performance seen in
patients with COPD. Decreased capacity of local muscle
endurance in both the upper and the lower limbs has
been shown in COPD patients compared to healthy con-
trols [8]. Different training modalities have been evalu-
ated to uncover the most effective way of training
patients with COPD. The primary methods of exercise
training within pulmonary rehabilitation have tradition-
ally been different types of exercises incorporating a
large amount of muscle mass. However, increased dys-
pnea during these whole body/large muscle mass exer-
cises cause many COPD patients to stop exercising
before their cardiovascular system or skeletal muscles
are maximally stressed [9]. Training using a reduced
muscle mass is a way of dealing with this issue. This has
been found to achieve a higher metabolic rate due to less
stress being placed on the respiratory system as ventila-
tion is decreased compared to whole body exercises [10].
For example, three recent studies have shown positive
effects of single limb training (SLT) (that is, one-legged
cycling/knee extensor training) in patients with COPD
[11-13]. Two of these studies [11,12] focusing on one-
legged cycling concluded that it was superior to two-
legged cycling regarding aerobic capacity for COPD
patients. Bjørgen and colleagues [11] also demonstrated
that the total amount of work was larger in the group
working with one leg at a time compared to the group
working with both legs simultaneously. This could be
somewhat explained by an increased capacity of local
muscle endurance due to increased oxygen uptake and
increased maximal mitochondrial respiration in working
muscles, as demonstrated in the one-legged knee exten-
sor training study by Brønstad and colleagues [13].
High-repetitive SLT (that is, exercising only one arm
or one leg at a time) using elastic resistance bands onthe upper and lower extremity muscles within an exer-
cise regimen have previously been used with success in
patients with chronic heart failure [14]. Elastic bands as
resistance have also been used in patients with COPD
[15], however the concept of incorporating upper as well
as lower extremity muscles within an SLT regimen has
not been tested in patients with COPD. A goal-based
multiple repetitions maximum (RM) test to obtain the
accurate load using elastic bands has previously been
used, though this is time consuming and could be antici-
pated to take between three and six attempts [16,17] for
each separate exercise. As far as we know, there are no
published studies investigating the effect of local high-
repetitive single limb exercises in patients with COPD.
In addition, because of the enhanced number of women
affected by COPD [2], a better understanding of the
effects of training in women is of importance. Previous
studies on SLT have only incorporated the leg muscles
(quadriceps in particular) [11-13]. To be able to optimize
training for all COPD patients while focusing on local
muscle endurance, a clinical trial incorporating upper as
well as lower extremity muscles is essential. In addition,
if the starting resistance is accurate for each targeted
muscle the amount of time exercising with adequate re-
sistance will increase.
Methods/design
This is a prospective, assessor-blind, block randomized
controlled, parallel-group multicenter trial constructed
in accordance with consolidate standards of reporting
trials (CONSORT) [18,19] guidelines (Figure 1).
Objectives
The aim of the current randomized controlled multicen-
ter trial (RCT) is to determine the effects of high-
repetitive single limb exercises (HRSLE) in combination
with COPD-specific patient education, compared to the
COPD-specific patient education alone in patients with
moderate to very severe (stage II-IV) COPD.
Primary outcomes
1. Lower extremity: determine the effects of HRSLE
on local muscle endurance capacity measured
as meters walked during 6-minute walk test
(6 MWT).
2. Upper extremity: determine the effects of HRSLE
on local muscle endurance capacity measured
as rings moved on 6-minute ring and
pegboard test.
3. Determine the effects of HRSLE on QoL measured
as the change in score on the Swedish version
of the chronic respiratory disease questionnaire
(CRQ-SAS).
Recruitment of eligible patients fulfilling inclusion criteria 
Reasons for exclusion 
Not meeting inclusion criteria  
Declined to participate  
 Other reasons  
Outcome measurement directly after end of intervention period 
Three occasions during two weeks 
Blinded outcome assessors 
Allocation to intervention group 
HRSLE and patient education 
8 week intervention period 
3 training sessions per week + 4 education sessions  
Allocation to control group 
Patient education 
8 week intervention period 





Baseline and inclusion measurements 
Four occasions during three weeks  
Reasons for exclusion 
Not meeting inclusion criteria  
Declined to participate  
 Other reasons  
Örnsköldsvik Hospital, 
Örnsköldsvik 
Karolinska University Hospital, 
Huddinge 
Norrlands University Hospital, 
Umeå 
Analysis 
Analysis of data 
Analyses of primary and secondary outcome measurements will 
include all randomized patients analyzed by original assigned group 
Pre-test
Stratification by center and gender 
Figure 1 Consolidate standards of reporting trials (CONSORT) flow diagram of trial design.
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1. Determine the effect of HRSLE on: 1) endurance
time, ventilatory response, perceived dyspnea and leg
fatigue during submaximal cycle test; 2) maximal
strength and muscular endurance during isokinetic
tests; and 3) self reported dyspnea, self-efficacy,
anxiety and depression.
2. Determine the relationship between: 1) changes in
self reported dyspnea, self-efficacy, anxiety and
depression; and 2) changes in exercise capacity
3. Identify if there are any sex-related differences in
exercise training effects.
4. Determine if this exercise regimen is feasible and
safe in stage II-IV COPD patients.5. Develop a strategy to minimize attempts needed to
determine a multiple repetition resistance using
elastic bands.
6. Develop a strategy to optimize resistance for
each involved movement within an exercise
regimen.
7. Investigate the relationship between muscle fatigue
and dyspnea in the different exercise tests.
Settings
The trial is conducted at three hospitals in Sweden: one
in the county of Västerbotten (Norrlands University
Hospital, Umeå), one in the region of Stockholm
(Karolinska University Hospital, Huddinge) and one in
the region of Västernorrland (Örnsköldsvik Hospital,
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tion of data started May 2011.
Eligibility criteria
Potentially eligible participants are being identified
through screening of patient medical records at partici-
pating hospitals as well as medical records from primary
care centers in the vicinity of each hospital. Inclusion
criteria are verified through information obtained from
patient medical records in three steps.
(1) Screening is performed by one of the authors (AN)
who divides screened medical records into
three groups: (a) eligible, (b) potentially eligible,
and (c) excluded.
(2) Those found eligible or potentially eligible are
controlled and verified by a second author (KW)
or by pulmonary medical doctors at
respective hospital.
(3) If missing or unclear data is present in patient
medical records, information regarding
inclusion criteria is obtained from those
found eligible through standardized questions
during phone contact at the recruitment
process.
Inclusion criteria
1. Adults 40 years and above.
2. Stable (no exacerbations within 4 weeks before start
of baseline testing) moderate to very severe COPD,
stage II-IV, according to GOLD criteria [1] (that is,
forced expiratory volume in one second/forced
vital capacity< 0.70, forced expiratory volume in
one second< 80% predicted).
3. Ex-smoker.
4. Stable medical treatment (no changes< 4 weeks
before start of baseline testing).
5. Living less than 60 km from training facility.
Exclusion criteria
1. Musculoskeletal, rheumatic, cardiac or neurological
disorders that might affect the exercise performance
in training and tests.
2. Previous lung surgery.
3. Acute exacerbations of COPD that require a change
in pharmacological management within 4 weeks
preceding the start of the intervention.
4. Long-term oxygen treatment.
5. Participated in organized exercise training, > 2
times a week, within 6 months before start of
intervention.
6. Body mass index< 18 kg/m2.The following eligibility criteria will be used for the
local physiotherapists leading the exercise intervention
and giving the COPD-specific patient education.
Physiotherapist inclusion criteria
– Professional qualities for those leading exercise
intervention(1) At least 2 years experience of working as a
physiotherapist.
(2) At least 1 year experience of working with
COPD patients or 1 year with heart failure
patients.
(3) At least 1 year experience of leading training
groups.
– Professional qualities for those leading patient
education
(1) At least 2 years experience of working as a
physiotherapist.
(2) At least 1 year experience of working with
COPD patients.
(3) Previous experience of leading patient education
or pulmonary rehabilitation for
COPD patients.
Physiotherapists not fulfilling the above criteria will
be excluded.
Physiotherapist education
All physiotherapists leading the HRSLE will receive in-
dividual standardized education before the start of
intervention. The education lasts for 60 minutes and
consists of written, oral and visual instructions on how
to perform and instruct each exercise within the
HRSLE. It also includes instructions on how to pro-
gress exercise with the use of Borg CR10 [20], and
how to standardize exercises and positions during
warm-up, training and cool-down within the HRSLE
regimen.
The written information includes:
(1) A check-list for all sessions on what to do, before,
during and after each session (including placement
of equipment, exercise order, when to rate
muscular fatigue and dyspnea with Borg CR10, and
use of pulsoximetry).
(2) A comprehensive exercise protocol (see Additional
file 1).
(3) Rating sheets for muscular fatigue, dyspnea and
saturation.
(4) The written information given to participants in:
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b. The control groupDescription of intervention and comparator
Intervention treatment
The HRSLE regimen consists of three sessions per week
(Monday, Wednesday and Friday at approximately noon)
during 8 weeks of exercise training, giving a total num-
ber of 24 sessions. The HRSLE regimen is supervised
and conducted by local physiotherapists using a group
format, with four to eight participants in each group.
Each session will span approximately 60 minutes dur-
ation for the major components: 10 minutes warm-up
followed by 40 minutes of HRSLE, and then 10 minutes
cool-down.
Warm-up
The warm-up focuses on low intensity dynamic flexibil-
ity exercises of involved muscle groups to ensure ad-
equate range of motion, familiarization of exercises
movements and execution of motions at optimal velocity
to rehearse desired motion patterns as recommended by
the American College of Sports Medicine (ACSM) [21].
The following warm-up exercises will be performed al-
ternately left to right arm/leg.
Seated: heel raises, knee extension with heel touching
floor, hip flexion, rear deltoid row, chest press, knee ex-
tension with dorsal flexion of ankle, and biceps flexion
with vertical shoulder press.
Standing: walking, two-leg heel raises, hip flexion, sin-
gle leg anterior/posterior swing, knee extension with
heel touching floor, and leg curl.
High-repetitive single limb exercises using elastic bands
Exercise selection and equipment Important upper
and lower extremity muscle groups for COPD patients
have been identified through a literature search focusing
on muscles with decreased strength/endurance com-
pared to healthy individuals, upper extremity activities
important for daily living, and those important for walk-
ing [22-25]. Exercises have been identified for each of
the relevant muscle groups. Execution of each exercise is
standardized to optimize activation of targeted muscles
(for specific details see Additional file 1 [6,26,27]).
The exercise regimen will consist of eight exercises, of
which six single arm/leg exercises (primary muscle focus)
[22-25] - latissimus row (m. latissimus dorsi), chest press
(m. pectoralis major, m. deltiod anterior), leg extension
(m. quadriceps), straight arm shoulder flex (m. deltoid
anterior), leg curl (m. hamstrings) and elbow flexion
(m. biceps brachii) - are performed with elastic resistance
bands, so-called Thera-Bands (The Hygenic Corporation,
Akron, OH, USA). The elastic bands are fastened at thelowest and highest levels of wall bars present in training
facilities. Eight different Thera-Bands with increasing re-
sistance will be used in this trial: tan (extra thin)< yellow
(thin)< red (medium)< green (heavy)< blue (extra
heavy)< black (special heavy)< silver (super heavy)<
gold (maximum resistance). This allows suitable resist-
ance for each individual and a graded increase in work
load during exercises [14]. A change from one color to
another results in an increased resistance of 20 to 30%
[28]. The two other exercises, single leg heel raise (m. tri-
ceps surae) and single leg step-up (m. quadriceps, m.
iliopsoas), are performed with body weight as the pri-
mary resistance. Elastic resistance is incorporated when
progression occurs.
Volume and load Unilateral exercises with high repeti-
tions are selected for this trial in line with recommenda-
tions of the ACSM [29]. Unilateral exercises are chosen
to minimize the involved muscle mass to customize the
intervention for the patients with COPD. High-
repetition exercises are also recommended both by
Ebben and colleagues [30], for untrained individuals to
improve endurance, and by Campos and colleagues [31],
who found significant increases in aerobic power and
time to exhaustion after high-repetition exercises (20 to
28 repetitions, 1 minute rest).
Rest periods The rest period chosen in this trial is 1 mi-
nute, as previously used [31] and recommended when
the number of repetitions exceeds 15 for local muscle
endurance [29].
Frequency The exercise regimen will be performed
3 days per week [29].
Repetition velocity Moderate to fast velocities are
recommended when performing a larger number of
repetitions (that is, at least 15 repetitions). In this trial,
we will execute 25 repetitions with 1 second in the con-
centric contraction phase and 1 second in the eccentric
contraction phase. This means that we can keep the rest
intervals within 1 minute as recommended [29].
Progression The resistance for each exercise will be in-
dividually determined and progressed to optimize indi-
vidual tailoring of the exercise regimen. Progression will
be done separately for the six exercises using elastic
resistance, the single leg-heel raise and the single leg
step-up. Progression will be executed with the use of in-
dividual ratings of muscle fatigue and dyspnea according
to the Borg CR10 scale [20] following a specified proto-
col: if a patient rates< 4 on muscle fatigue [32] and per-
forms ≥ 20 repetitions [29] in at least three of six elastic
resistance exercises it will result in an increase in
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rating of at least three out of six exercises> 5 on dyspnea
[33] will result in a decrease in resistance. The same
principle will be used on the single leg step-up and single
leg heel raise individually. The Borg scale has previously
been used on COPD patients after single leg exercises to
measure dyspnea and muscular fatigue [34] and when
rating exercise intensity using elastic resistance tubing
[35]. To progress, the criteria for rating should be ful-
filled in two subsequent sessions or two out of three fol-
lowing sessions. Progression in the six exercises with
elastic resistance band is executed by increasing the ten-
sion of the elastic band (for example, tan< yellow< red
< green< blue< black< silver< gold). Progression of
single leg heel raise is as follows: (1) heel raises on flat
surface, (2) heel raises on step-up board (allowing larger
range of motion), (3) heel raises on step-up board with
tan elastic resistance (fastening resistance band under
step-up board stretched to the lowest position on the
side of the exercising leg), and (4) heel raises on step-up
board with increased elastic resistance as described
above. Progression of step-up is as follows: (1) 15 cm
step-up board, (2) 20 cm step-up board, (3), 25 cm step-
up board, (4) 25 cm step-up board with tan elastic resist-
ance (fastening resistance band under step-up board
stretched to the lowest position on the side of the exer-
cising leg), and then (5) heel raises on step-up board with
increased resistance as described above.
Initial load To be able to enhance the accuracy of each
individual patient receiving adequate initial resistance
for each separate exercise we aim to use a three-step
approach:
1 A pilot study was performed on 30 healthy
individuals, in a similar age group as the patients
within this study. The results of the pilot study
showed a strong relationship between elastic
resistance maximal voluntary contraction (MVC)
and isokinetic peak value during shoulder flexion
with no significant difference in weight (kg). Based
on this pilot study, the peak value obtained from the
isokinetic tests at baseline within the present study
will be used to determine MVC (that is, 1 RM)
using elastic resistance [36]. Fifty-five per cent of the
isokinetic peak value will be used as 25 RM as
recommended by Page and Ellenbecker [36].
However, the choice of standardizing the training
load from a MVC using elastic resistance has been
questioned. Therefore, a goal-based 25 RM test will
also be performed [37]. The number of attempts
needed to reach 25 RM will be recorded.
2 Based on a literature search the following percentage
strength relationships between involved muscles forCOPD patients during the movements that are
involved in this HRSLE were identified (described as
weight at end position if knee extension is seen as
maximal): knee extension (100%), chest press (85%),
leg curl (65%), elbow flexion (50%), latissimus
row (35%), shoulder flexion (30%). For example, if
10 kg is considered 55% of 1 RM for knee extension,
3 kg would be considered 55% of 1 RM for
shoulder flexion.
3 According to the strength relationship between
involved muscles and information obtained
regarding the weight properties of elastic resistance
at a given length (Thera-Band values provided by
the manufacturer; The Hygenic Corporation), the
distance from insertion for each exercise using
elastic resistance is determined
(see Additional file 2).
By using different starting positions for each exercise
(that is, the elastic tubing is stretched to different
lengths resulting in different resistances at every pos-
ition) we hope to be able to optimize the resistance for
the involved muscle during each separate exercise. Two
elastic resistance bands (the same color) will be needed
(one fastened at the lowest level of the wall bar and the
other fastened at the highest level) for all elastic exer-
cises within the HRSLE.
Cool-down
Cool-down will consist of five stretching exercises for
involved muscle groups. Holding each stretch for 30 sec-
onds to mild discomfort, with two repetitions for each
limb (that is, 2 minutes active stretching for each
muscle), targeting the pectoralis major, biceps brachii,
hamstrings, quadriceps and triceps surae, is in accord-
ance with recommendations of the ACSM [38]. Selection
of muscles is based on involvement in the HRSLE regi-
men. In addition, the intervention group receives stan-
dardized patient education on four occasions during an
8-week period. Each session lasts 60 minutes, and con-
sists of information regarding anatomy, physiology,
COPD (causes and mechanisms), nutrition, aids/tools
and energy saving procedures.
Standardization To enhance repeatability of this
HRSLE regimen, the following key elements are being
standardized:
– The length of each individual elastic band is
between 3 and 3.5 m (depending on color). The
different colors result in different lengths needed for
handles and insertion - for example, 1 to 1.5 m is
used for insertion and handles and the 2 m
remaining results in 1 m to the left and right limb
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resistance bands from insertion are, as a
consequence, standardized to 1 m for each side,
pre-stretched 20 times to stabilize the
material [39].
– Individual starting resistance (color of elastic
resistance band) is standardized from isokinetic
baseline isokinetic peak value in shoulder flexion
and then altered for other exercises according to the
strength relationship between the involved muscles
for each respective participant.
– Distances from elastic resistance insertion for each
exercise are standardized, with different colored
cones, to optimize adequate resistance for targeted
muscle groups. The distance away from insertion for
each exercise is based on a literature search of
strength relationships between involved muscles for
COPD patients and information obtained from the
manufacturer regarding the properties of elastic
resistance (Additional file 2).
– The elastic resistance has been tested for 5,040
cycles with less than 1.1 Newton change in force-
generating potential [39]. To obtain the same force-
generating potential of the elastic resistance, the
bands are changed every eight sessions using a
consistent color used based on the following
calculations: each exercise is 25 repetitions twice for
each extremity = 100 repetitions per exercise, with
elastic resistance for six exercises = 600 repetitions
per session; 600 times 8 sessions = 4,800 repetitions.
– Start and stop positions are standardized for each
exercise and executed to optimize activation of
targeted muscles for each exercise separately.
– The most clinically effective degree of elastic
resistance is 25% to 250% elongation; all exercise
start and stop positions are within this interval [36].
– Individual progression is standardized using Borg
CR10 according to a specified protocol (see
Progression section above for more detail). For
specific details of progression for each exercise see
the HRSLE section above.
– The targeted velocity - that is, 1 s concentric, 1 s
eccentric (60 beats/minute) - for seven out of eight
exercises is standardized by counting by the
physiotherapist leading the training sessions. In
addition, music at twice the pace (around
120 beats/minute) will be used to assist the
physiotherapists and patients.
– The standardized exercise protocol (Additional file
1) will be given to both participants and
physiotherapists to enhance adherence and
familiarization.
– Patient education material is standardized and the
same for all locations.– Physiotherapists are given standardized education to
uniformly deliver the intervention.
In addition to the exercise protocol, standardized
instructions on exercise progression and distance from
elastic resistance insertion for each exercise (as
described above) will be given to the physiotherapists
leading the training to enhance adherence. Furthermore,
written commitments to follow the assigned protocol
will be signed by all physiotherapists and adherence to
trial protocol will be evaluated by a questionnaire after
the end of intervention for both participants and
physiotherapists.
Comparator
The control group receives standardized patient educa-
tion four times during the 8-week intervention period.
Each session lasts 60 minutes, and consists of informa-
tion regarding: anatomy, physiology, COPD (causes and
mechanisms), nutrition, aids/tools and energy saving
procedures. The information is the same as for the inter-
vention group, but given on separate occasions. After
post-tests, the participants in the control group will be
offered participation in a training intervention.
Standardization To enhance repeatability of patient
education, the following key elements are being
standardized:
– Patient education material is standardized and the
same for all locations.
– Physiotherapists give informed consent to follow the
standardized instructions regarding the patient
education materials.
Screening tests and outcome assessment
Different tests will be performed before the start of the
study and directly after the 8-week intervention period
at Norrlands University Hospital, Umeå, and Karolinska
University Hospital, Huddinge. Participants at Örns-
köldsvik Hospital, Örnsköldsvik, will perform tests at
Norrlands University hospital, Umeå, due to lack of spe-
cific test equipment. The primary outcome measures will
be assessed by the same researcher (AN) for all partici-
pants at each location. Pre-tests will be performed on
four occasions, within 3 weeks, before the start of inter-
vention, and post-tests will be performed on three occa-
sions within 2 weeks. Each test occasion will last from 1
to 2 h. Pre- and post-tests will be performed at the same
time of day, with the same rest between test occasions
and during tests. Since a subject's motivation may deter-
mine attainment of maximal effort [7], both pre- and
post-tests are performed using standardized information
and encouragement [32]. No additional follow-up apart
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used within this trial. However, previous studies show
that the benefits of exercise training on exercise capacity
and QoL in patients with COPD appear to decline by 12
to 24 months despite different exercise strategies [40,41].
There is an urgent need to find effective strategies on
how to maintain the positive effects for a longer period.
Therefore, in connection with the study described in this
protocol, a randomized controlled study is planned to
evaluate the effect of motivational interviewing as a
strategy to maintain/increase the level of physical activity
after a training program (and by that also the benefits
achieved from the training program). Participants rando-
mized to the intervention group will be asked to partici-
pate, and follow-up tests will be performed at 6, 12 and




Spirometry, body plethysmography, and single-breath
diffusing capacity maneuver will be performed using
the Jaeger Masterscreen Body (CareFusion, GmbH,
Hoechberg, Germany) at Umeå University Hospital or
at Huddinge University Hospital in accordance with
recommended techniques [42,43].
Cardiopulmonary exercise testing - incremental
Symptom-limited exercise tests will be conducted on an
electronically-braked cycle (Rodby RE 990 1063, Hagby,
Sweden) at the Department of Clinical Physiology, Umeå
University, and at Karolinska University Hospital, Hud-
dinge, in accordance with clinical exercise testing guide-
lines [44]. An incremental exercise test with work rate
increments of 10 Watts per minute until symptom limi-
tation will be performed. Patients will rate their dyspnea
and leg fatigue according to the Borg CR-10 scale [20]
every minute during the test. Watts maximum (Wmax) is
defined as the greatest work rate that the subject is able
to maintain for at least 30 s.
Outcome measures
Cardiopulmonary exercise testing – constant work rate
Constant work rate exercise tests will be performed at
75% Wmax (obtained from cardiopulmonary exercise
testing (CPET) – incremental test). Endurance time will
be recorded as the time from the increase in work rate
to 75% Wmax to the point of symptom limitation. During
the constant-load exercise test, measurement of ventila-
tion, oxygen uptake and carbon dioxide production will
be measured by ergospirometry (VMAX Encore 229,
CareFusion, Palm Springs, USA in Huddinge and Jaeger
Oxycon, CareFusion, GmbH, Hoechberg, Germany in
Umeå). CPET is considered the gold standard formeasuring the level of exercise limitations of a patient
and is often used in patients with COPD [45].
Field test
The following tests will be performed at the department
of Community Medicine and Rehabilitation, Physiother-
apy, Umeå University, and at the Physiotherapy division
in Karolinska University Hospital, Huddinge: dyspnea
and muscle fatigue in the legs and arms, depending on
the test, will be measured with the Borg CR10 [46], and
oxygen saturation and pulse will be measured with pul-
soximetry (Nellcore NPB-40, Pleasanton, CA, USA) be-
fore and directly after each test. The Borg CR10 scale
has previously been used to evaluate dyspnea, breath-
lessness and leg discomfort in COPD patients [47] and is
found to be reliable [48].
Upper extremity Primary outcome: To assess functional
muscular capacity in the upper extremity, the 6-minute
pegboard and ring test will be used [49]. The pegboard
and ring test consists of a peg board with the pegs set at
the subject’s shoulder height and 10 cm below shoulder
height. The pegs will be at shoulder width; three differ-
ent insertions are available (45, 50 and 55 cm width) to
be suitable for all participants. The rings consist of 10
lightweight wooden rings (6 g each) that the subject
moves simultaneously from the upper pegs to the lower
pegs repeatedly [50]. The subjects are asked to move as
many rings as possible in 6 minutes and the final score
is the total number of rings moved in the given amount
of time. Standardized encouragement will be given to
the subjects each minute. All subjects will move 20 rings
from the lower to the upper pegs and reverse prior to
the test to familiarize themselves with the test procedure
and lower the risk for learning effect. The 6 minute peg-
board and ring test has previously been used on COPD
patients [51] and shows excellent test-retest reliability
[49]. To measure unsupported endurance capacity, the
Unsupported Upper Limb Exercise test (UULEX) will be
used [52]. The patients hold a plastic bar (0.2 kg) at
shoulder width. The UULEX consists of eight levels;
the patients perform each level for 1 minute, lifting the
plastic bar at a cadence of 30 beats per minute, con-
trolled with a metronome, from the hip to the UULEX
eight level chart. The tests starts with a 2-minute warm
up at the lowest level; the warm up is included in the
final time. The first level is adjusted to be at the level of
the patient’s knees by altering the position of the
UULEX chart on the wall. Once they have reached their
maximum height the bar will be replaced with a heavier
one (0.2< 0.5< 1< 1.5< 2 kg). The patients are
instructed to perform the test until symptom limitation.
The UULEX has previously been used on COPD
patients [51].
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used to assess lower extremity functional muscular en-
durance and walking capacity. The 6 MWT is widely
used on COPD patients for measurement of endurance
walking capacity [53]. In this study we expect to see a
difference of 50 m based on a recent published RCT on
unsupported training and COPD [54]. The walking
course will be 30 m in length and the patients will be
instructed in accordance with standardized guidelines
[55] to walk as far as possible in 6 minutes. One practice
test will be performed to minimize risk of learning effect.
The highest value will be chosen as the baseline value.
Peripheral muscle strength
Isokinetic muscle strength (maximal and endurance) in
the leg (knee extension) and the arm (shoulder flexion)
will be evaluated by the use of two interchangeable sta-
tionary dynamometers: the Biodex Multi-Joint System 3
(Biodex Corp., Shirley, NY, USA) at the Department of
Community Medicine and Rehabilitation, Physiotherapy,
Umeå University; and The Biodex Multi-Joint System 4
(Biodex Corp., Shirley) at Karolinska University Hospital,
Huddinge. The tests will be performed unilaterally on
the self-reported, dominant side. Subjects will be seated
in accordance with the manufacturer’s recommenda-
tions. The 6 MWT is performed before the isokinetic
tests and will be considered as a warm-up. Before both
maximal tests the participants will perform five submax-
imal contractions to familiarize themselves with the
equipment and testing procedure, followed by 2 minutes
standardized rest before the start of testing [32].
Shoulder flexion Test of shoulder flexion will be per-
formed between 0° and 100°; great care will be taken to
align the glenohumeral joint with the movement axis of
the Biodex dynamometers (The Biodex Multi-Joint Sys-
tem 3 and 4 (Biodex Corp., Shirley)). The arm will be
held with the elbow extended and the forearm semi-
pronated [56].
Knee extension The test of knee extension will be per-
formed between 90° flexion to maximal knee extension
−5°. Full extension −5° will be used to lower the risk for
a passive resistance from the hamstring muscle during
knee extension. Great care will be taken to align the lat-
eral femur epicondyle with the movement axis of the
Biodex dynamometers (The Biodex Multi-Joint System 3
and 4 (Biodex Corp., Shirley)). Positioning of partici-
pants, equipment, and range of motion will be docu-
mented to be the same during pre- and post-tests. Two
different aspects of isokinetic muscle strength will be
measured. Firstly, a maximum contraction test measur-
ing peak torque (Nm) from the highest contraction at an
angular velocity of 60°per s, generated through fivemaximal contractions, will be performed as previously
used and recommended for COPD patients [57-59]. The
subjects are told to flex their arm or extend their leg five
times in a row with maximal effort during the concentric
phase and to rest during the eccentric phase. Secondly,
after a recovery period of 5 minutes [32,59], an endur-
ance test consisting of 30 consecutive repetitions [59] at
60°per s measuring total work (joules) will be per-
formed. The subjects are told to flex their arm or extend
their leg 30 times using maximal effort at each repetition
during the concentric phase and to rest during the ec-
centric phase. The angular velocity of 60°per s is consid-
ered ideal for evaluating muscle strength in COPD
patients [57] and is found reliable in endurance tests
[60]. No visual feedback is given during tests. Standar-
dized encouragement is given.
Chronic dyspnea questionnaires
The Medical Research Council (MRC) Dyspnea scale is a
five-point scale based on degrees of various physical ac-
tivities that cause dyspnea [61] and will be used to grade
the patients’ inconvenience. The MRC dyspnea scale has
been used in numerous clinical trials involving COPD
[62], and is shown to be valid in COPD patients [63].
Health-related quality of life
Primary outcome The CRQ-SAS version of the CRQ
[64] will be used to assess QoL. The CRQ is a widely
used disease specific questionnaire to assess symptoms
of COPD patients [65]. The Swedish CRQ-SAS consists
of 20 health-related questions. The Swedish version of
the Clinical COPD questionnaire (CCQ) will also be
used to assess disease-specific QoL [66]. The CCQ has
been shown to be valid and reliable in Swedish patients
with COPD [67] and consists of 10 questions. The Swed-
ish SF-36 will be used for the assessment of QoL. SF-36
is a 36-item questionnaire used to evaluate QoL through
eight subscales: physical functioning, role-physical, role-
emotional, social functioning, general health, mental
health, bodily pain and vitality [68]. The SF-36 has previ-
ously been used in the assessment of QoL in COPD
patients [69] and is considered the gold standard generic
health assessment tool [70], being both valid, reliable
and vigorously tested [68].
Anxiety, depression and self-efficacy
The Hospital Anxiety and Depression Scale (HADs) will
be used for assessment of anxiety and depression. HADs
consists of 14 items, producing separate scores for anx-
iety and depression [71]. The questionnaire is widely
used in association with COPD [72]. The Swedish ver-
sion of the Exercise Self-Efficacy Scale (ESES) [73] will
be used to investigate self-efficacy. The ESES consists of
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validity and reliability tests.
The Self Efficacy for Walking Questionnaire will
be used to assess the patients self efficacy in associ-
ation with physical activity, and the questionnaire
has been used in intervention studies on patients with
COPD [74].
Feasibility
Feasibility will be evaluated through attendance, adher-
ence and development of any side effects or injury dur-
ing each training session. In addition, compliance to the
different parts of the HRSLE will be evaluated with a
standardized questionnaire by both study participants
and the physiotherapists leading the interventions.
Training resistance
To determine starting resistance (color of resistance
band) a 25 RM shoulder flexion test will be performed,
standing using the dominant arm, during baseline tests.
The exercise movement will be instructed orally and
visually by the primary investigator (AN). The following
familiarization strategy will be used: 25 repetitions will
be performed with the non-dominant arm using the low-
est level of resistance (tan elastic band) to familiarize the
patient with the exercise movement [37]. During
familiarization, the patient will receive instructions to
perform the exercise accurately - arm kept straight
(elbow extended) throughout the whole movement hold-
ing the band in full can position with thumb pointing
upwards; lifting the arm upwards/forward until the
elbow passes the patient’s chin returning to the start
position in a controlled manner with the same speed
[27]. Length of the elastic band will be 1 m, stretched
25% at the start and proximally 75% at the end position,
that is 1.75 m at the end position. During the test the
patient will be instructed to perform as many repetitions
as possible, and no additional feedback or encourage-
ment will be provided. The 55% of peak value obtained
during isokinetic shoulder flexion will be obtained and
the elastic resistance band closest to this value at 75%
elongation will be used. A change of elastic band results
in a weight difference of 20 to 30% [28], and between 20
and 30 repetitions are considered 25 RM. The number
of attempts needed to reach 25 RM will be recorded.
Five minutes rest between attempts will be provided if
necessary. Rating of muscle fatigue and dyspnea after
each exercise using BORG CR10 will be recorded for
each participant randomized to the intervention group.
Sample size
A sample size of 17 in each group (intervention, control)
will be required to obtain the power to detect a signifi-
cant difference in lower limb local muscular endurancecapacity measured by the 6-MWT [53]. The sample size
calculation was made with the following assumptions: a
relevant mean difference of 50 meters walked in 6 min-
utes with a standard deviation (SD) of 52, α= 0.05,
β= 0.20 (80% power); and a two-tailed test of signifi-
cance, based on a study by Costi and colleagues [54] (a
RCT published in 2009 on unsupported training in
patients with COPD). For QoL, the sample size calcula-
tion was made with these assumptions: a relevant mean
difference of 1 unit (SD 1.07) on the Swedish version of
the CRQ, α= 0.05, β= 0.20 (80% power); and a two-
tailed test of significance, data based on CRQ values
obtained in the study by Lacasse and colleagues [75]
gave 17 patients in each group. Multicenter trials involve
a correlation in data - subjects from the same center are
likely to be more similar than subjects from other cen-
ters. Because such a correlation potentially affects the
power of the data within the trial, the sample size needs
to be adjusted, often increased, to account for the design
of the study - in other words, the design effect [76]. Sev-
eral considerations have been made to minimize the ef-
fect of using different centers: the same inclusion
criteria for participants at all locations; specified and
similar inclusion criteria for physiotherapists at all loca-
tions; standardized training for all physiotherapists to
uniformly deliver the intervention; all aspects of the
intervention regimen are standardized; a standardized
exercise protocol will be given to both physiotherapists
leading interventions and participants; physiotherapists
give informed consent to follow the standardized
instructions regarding the standardized patient educa-
tion material; and exercise protocol and primary out-
come measures are measured by the same (blinded)
outcome assessor at all centers during pre- and post-
tests. In addition, in an individually randomized trial,
stratified for centers, the design effect is estimated to be
< 1 which involves a gain in power, allowing a reduction
in sample size rather than an increase [76,77]. With re-
gard to the design of the study and the considerations
taken to minimize the effect of using different centers,
no adjustment of sample size will be made due to design
effect. Nevertheless, the sample size is adjusted for po-
tential drop-outs. We expect a drop-out rate of 20%
based on a previous systematic review [78]. We aim to
recruit five additional patients to each group, resulting
in a total number of 44 patients, 22 in each group (17/
0.8 = 21.3 22) with moderate to very severe COPD.
The total study group will consist of an equal number of
males and females.
Randomization and blinding
To prevent knowledge of treatment assignment and to
keep the allocation sequence concealed from the partici-
pants and the researchers, group allocation will be
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formed by an individual independent of the recruitment
process. This person will, after enrollment of partici-
pants, be emailed participation details and then perform
the randomization using a randomly permuted blocks
design with a computer random number generator
(www.randomization.com). Randomization will be strati-
fied by center and gender with a 1:1 allocation to the
intervention or control group using random block sizes.
The assignment to groups after randomization will be
performed by a third party independent of the recruit-
ment process for allocation and randomization. After
randomization the allocation sequence will be kept in an
opaque, sealed and stapled envelope, locked away in a
safe deposit box at the department of Community Medi-
cine and Rehabilitation, Physiotherapy, Umeå University,
Umeå, and will be kept concealed until the end of out-
come assessment. The envelope will be made imperme-
able to intense light by using aluminum foil inside and
sealed using tamper-proof labels. Furthermore, the parti-
cipants will be given repeated instructions not to reveal
their group allocation to the outcome assessors during
post-tests after the end of the intervention period. In
case of a failure in keeping the outcome assessor blinded
(that is, a patient reveals his/her group allocation) a sec-
ond trained outcome assessor will be available to step in
and conduct the post-tests.
Statistics
The analysis of primary and secondary outcome mea-
surements will include all randomized patients. To be
able to use all patient data, the mixed models approach
will be adopted with individuals at level one and center
at level two. The analysis will demonstrate any improve-
ments at follow-up, comparing the intervention and
control group. In linear mixed models the variable group
is considered main, controlling for baseline value, center
and gender. To judge the quality of the model we will
analyze the residuals. A difference at the P< 0.05 level
will be considered significant in all outcome measures
and analyses. For each outcome the results will be
reported as a summary of the outcome in each group
presented as mean and SD, together with effect size. For
treatment effect, 95% confidence intervals (CI) and P
values will be presented. For each group, information
about the number of participants included in each separ-
ate analysis and whether theses analyses were by original
assigned groups will be given. Correlation between
changes in physical variables and changes in health vari-
ables will be measured by Pearson correlation. A pre-
specified subgroup analysis of participants randomized
to the intervention group will be performed to investi-
gate differences in BORG CR10 rating between elastic
resistance exercises to evaluate the strength relationshipbetween involved muscles/movements. Our research
group has previously found relatively lower thigh muscle
strength in female patients with COPD compared to
male patients with COPD and healthy controls [32]. In
addition, Skumlien and colleagues [79] found gender dif-
ferences regarding effects following a pulmonary re-
habilitation program and further research regarding the
potential differences in training effects between female
and male patients with COPD is required. Therefore, we
aim to compare primary and secondary outcome mea-
sures for males versus females in pre-specified subgroup
analyses to gather information for future studies.
Intention-to-treat analysis will be used for all outcome
measurements and involve all patients who are randomly
assigned. Mixed models will be used to handle missing
outcome data. In addition, within the main analysis, an
on-treatment analysis will be executed. On-treatment is
defined as at least 80% compliance - in other words, at
least 20 training sessions or three education sessions de-
pending on group allocation. For data management and
statistical analysis the IBM Statistical Package for Social
Sciences (SPSS) version 20.0 will be used.
Ethical approval and informed consent
The study has been approved by the regional ethical
board, Umeå, Sweden. Dnr: 2010-344-31 M. All partici-
pants will receive brief and comprehensible oral and
written information, in accordance with the Helsinki
declaration [80]. Informed, written consent is obtained
from all participants by one of the researchers (AN) be-
fore baseline tests.
Discussion
The HRSLE trial is, to our knowledge, the first trial in-
vestigating the effect of high-repetitive single limb exer-
cises in moderate to severe COPD patients. This is a
well designed study in strict accordance with CONSORT
guidelines, which will give us the opportunity to deter-
mine the effects of the HRSLE regimen used within this
trial. A problem in many previous exercise studies is the
lack of standardization which makes reproducibility diffi-
cult. The comprehensive standardization in this trial
facilitates the reproducibility of this trial. There is evi-
dence that a higher metabolic rate is achieved by train-
ing using a reduced simultaneous muscle mass in the
form of single limb training (that is, training using one
leg/arm at a time) in COPD patients. This is due to less
stress being placed on the respiratory system as ventila-
tion is reduced compared to whole body exercises
[10,81]. Previous studies indicate that single limb exer-
cise regimens seem more effective regarding total work
conducted during exercise compared to using a larger
amount of muscle mass [11,12]. This project will give
important information about a single limb exercise
Nyberg et al. Trials 2012, 13:114 Page 12 of 14
http://www.trialsjournal.com/content/13/1/114regimen that gives patients the opportunity to incorpor-
ate both upper as well as lower extremity muscles within
the same exercise regimen maintaining a low simultan-
eous impact on the ventilatory system. To find adjunct-
ive exercise strategies is of great importance to optimize
the treatment of the growing population of COPD
patients. The results of this project will most likely influ-
ence how we treat COPD patients in the future. The
number of females with COPD is increasing but most of
the previously conducted exercise trials involve a major-
ity of men. It is very important to investigate if the treat-
ment effects differ between men and women to be able
to optimize the treatment for all patients suffering from
this troublesome disease. This RCT will contribute to
the existing knowledge regarding potential sex-related
differences in physiological response to exercise training.
Adequate resistance for each separately involved muscle
within an exercise regimen is of importance to optimize
the training effects. If we could minimize the attempts
needed to reach adequate resistance and provide accur-
ate resistance for each involved muscle the effects of the
exercise training could increase.
Trial status
The trial is currently recruiting participants at time for
submission of trial protocol 2012-02-10.
Trial registration
The clinical trial has been registered before the enroll-
ment of the first participant. Date of trial registration:
2011-05-11. Date of first participant randomized: 2011-
09-02. ClinicalTrials.gov identifier: NCT01354067. Trial
registration has been based on the WHO registration ad-
visory group minimal registration set [82].
Additional files
Additional file 1: High-repetitive single limb exercise (HRSLE)
program. Received by both physiotherapists leading training
intervention (during education) and participants (at first training session)
[6,26,27].
Additional file 2: Placement of participants during each exercise.
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